RxDoctor Payments DataLook up a doctor →

Anne Dow, NP

Nurse Practitioner · Syracuse, NYNPI 1356481253

Payments from drug & device makers

$15,251in general payments, 2019–2025

Across 623 payments — averaging $24.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Livanova USA, Inc.$3K
  • AbbVie$2K
  • Abbott$2K
  • UCB, Inc.$729
  • Pfizer$528
  • EMD Serono, Inc.$485
  • plus $7K from 52 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Livanova USA, Inc.11$2,684
AbbVie192$2,258
Abbott19$1,685
UCB, Inc.24$729
Pfizer34$528
EMD Serono, Inc.14$485
Biogen31$442
Amneal Pharmaceuticals LLC30$432
SK Life Science, Inc.10$399
Lilly USA, LLC19$361
Novartis13$310
Lundbeck LLC13$289
Biohaven Pharmaceuticals, Inc.21$278
Sanofi11$258
AstraZeneca9$237
Otsuka America Pharmaceutical, Inc.13$228
Kyowa Kirin, Inc.10$220
TG Therapeutics, Inc.8$211
Biohaven Pharmaceutical Holding Company Ltd.17$203
Argenx US, Inc.7$201
Neurocrine Biosciences, Inc.8$196
Eisai Inc.7$192
Genentech USA, Inc.9$171
Averitas Pharma Inc.3$169
Teva Pharmaceuticals USA, Inc.9$160
Acadia Pharmaceuticals Inc8$140
Jazz Pharmaceuticals Inc.5$138
Amgen5$127
Takeda Pharmaceuticals U.S.A., Inc.5$122
Impel Pharmaceuticals LLC5$102
MDD US Operations, LLC3$95
Mallinckrodt Hospital Products Inc.3$83
Tanabe Pharma America, Inc.3$73
Johnson & Johnson4$70
Merz Pharmaceuticals, LLC3$69
Supernus Pharmaceuticals, Inc.2$68
Vanda Pharmaceuticals Inc.2$63
Axsome Therapeutics, Inc.2$61
Novo Nordisk3$55
Mylan Specialty L.p.2$51
Bristol Myers Squibb2$50
Xeris Pharmaceuticals, Inc.2$49
ANI Pharmaceuticals, Inc.2$49
Azurity Pharmaceuticals, Inc.2$47
Impel Pharmaceuticals Inc.2$44
Sumitomo Pharma America, Inc.2$43
Acorda Therapeutics, Inc2$41
Neurelis, Inc.1$40
Catalyst Pharmaceuticals, Inc.1$40
Life Molecular Imaging Ltd1$33
Medtronic1$32
Avion Pharmaceuticals2$25
Banner Life Sciences, LLC1$24
Cycle Pharmaceuticals Inc1$23
Scilex Pharmaceuticals Inc.1$23
Avadel CNS Pharmaceuticals, LLC1$15
Collegium Pharmaceutical, Inc.1$14
Arbor Pharmaceuticals, Inc.1$14

How this compares

$15,251 in reported general payments places this provider in the 95th percentile of 4,112 nurse practitioner providers in New York.

See all nurse practitioner providers in New York

Medicare billing

Part B allowed, 2024
$33,990
Medicare patients
182
Services billed
512

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Syracuse

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →